Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLRB Cellectar Biosciences Inc.

交易中 07-17 15:50:53 EDT

2.61

-0.18

-6.38%

最高2.76	最低2.58	成交量29.14万
今开2.75	昨收2.79	日振幅6.63%
总市值9,364万	流通市值7,135万	总股本3,585万
成交额76.89万	换手率1.07%	流通股本2,732万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences Inc.","latestPrice":2.612,"timestamp":1721245795207,"preClose":2.79,"halted":0,"volume":291403,"delay":0,"floatShares":27317184,"shares":35848924,"eps":-3.045096,"marketStatus":"交易中","marketStatusCode":2,"change":-0.178,"latestTime":"07-17 15:50:53 EDT","open":2.75,"high":2.76,"low":2.575,"amount":768877.9179543,"amplitude":0.066308,"askPrice":2.62,"askSize":513,"bidPrice":2.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.045096,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721246400000},"adr":0,"adjPreClose":2.79,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.79,"preClose":2.79,"latestTime":"09:17 EDT","volume":2740,"amount":7644.80002,"timestamp":1721222255737},"postHourTrading":{"tag":"盘后","latestPrice":2.79,"preClose":2.79,"latestTime":"18:57 EDT","volume":1650,"amount":4603.5,"timestamp":1721170642070},"volumeRatio":1.112043,"impliedVol":2.2004,"impliedVolPercentile":0.8793},"requestUrl":"/m/hq/s/CLRB","defaultTab":"news","newsList":[{"id":"2452491211","title":"Cellectar Biosciences, Inc.盘中异动 临近午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452491211","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452491211?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:58","pubTimestamp":1721145514,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时58分，Cellectar Biosciences, Inc.股票出现异动，股价快速拉升5.08%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Silo Pharma, Inc.、Nutriband Inc C/Wts 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3166.95%、1262.12%、378.23%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.，振幅分别为79.41%、61.68%、57.94%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162358349681d3c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162358349681d3c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2450364370","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.11%报2.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450364370","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450364370?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:05","pubTimestamp":1720710329,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日23时05分，Cellectar Biosciences, Inc.股票出现异动，股价急速上涨5.11%。截至发稿，该股报2.47美元/股，成交量11.0283万股，换手率0.31%，振幅5.32%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Okyo Pharma Ltd Com Npv 涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为602.42%、523.29%、390.97%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited，振幅分别为149.07%、88.60%、82.31%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112305299681c0d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112305299681c0d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2449492706","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.44%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449492706","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449492706?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:02","pubTimestamp":1720447330,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时02分，Cellectar Biosciences, Inc.股票出现异动，股价大幅拉升5.44%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Morphic Holding, Inc.、Virpax Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为817.27%、161.43%、133.76%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为65.74%、36.60%、34.48%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082202119681aa9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082202119681aa9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB","VRPX","BK4007"],"gpt_icon":0},{"id":"2449997312","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449997312","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449997312?lang=zh_cn&edition=full","pubTime":"2024-07-05 23:16","pubTimestamp":1720192571,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日23时16分，Cellectar Biosciences, Inc.股票出现波动，股价快速跳水5.26%。截至发稿，该股报2.34美元/股，成交量8.5502万股，换手率0.24%，振幅4.45%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Annovis Bio, Inc.涨幅较大，Kintara Therapeutics, Inc.、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.较为活跃，换手率分别为11593.58%、2120.01%、92.28%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Annovis Bio, Inc.，振幅分别为151.52%、61.48%、46.66%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052316119681a2e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052316119681a2e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139","ANVS"],"gpt_icon":0},{"id":"2448195071","title":"Cellectar Biosciences, Inc.盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448195071","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448195071?lang=zh_cn&edition=full","pubTime":"2024-07-03 03:20","pubTimestamp":1719948039,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日03时20分，Cellectar Biosciences, Inc.股票出现异动，股价急速跳水5.10%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Annovis Bio, Inc.、Zura Bio Limited C/Wts 、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Annovis Bio, Inc.、Geovax Labs, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为320.82%、70.52%、63.95%，振幅较大的相关个股有Annovis Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为151.42%、72.83%、53.12%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703032040af9037f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703032040af9037f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139","ANVS"],"gpt_icon":0},{"id":"2446559514","title":"Cellectar Biosciences, Inc.盘中异动 急速下跌5.54%报2.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446559514","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446559514?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:12","pubTimestamp":1719497537,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时12分，Cellectar Biosciences, Inc.股票出现异动，股价大幅跳水5.54%。截至发稿，该股报2.73美元/股，成交量13.4309万股，换手率0.37%，振幅3.11%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Geovax Labs, Inc.、Nls Pharmaceutics Ltd.、Kala Bio, Inc.较为活跃，换手率分别为1252.20%、236.19%、221.50%，振幅较大的相关个股有Geovax Labs, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd.，振幅分别为124.57%、112.22%、79.30%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627221217af8f8b34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627221217af8f8b34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2446964523","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.17%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446964523","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446964523?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:33","pubTimestamp":1719408801,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时33分，Cellectar Biosciences, Inc.股票出现波动，股价大幅上涨5.17%。截至发稿，该股报2.84美元/股，成交量8271股，换手率0.02%，振幅0.74%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Anew Medical, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为303.73%、63.07%、62.68%，振幅较大的相关个股有Anew Medical, Inc.、Atossa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为37.85%、20.87%、19.51%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213321aef6be47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626213321aef6be47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2446876741","title":"Cellectar Biosciences, Inc.盘中异动 大幅下挫5.59%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446876741","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446876741?lang=zh_cn&edition=full","pubTime":"2024-06-26 04:01","pubTimestamp":1719345681,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日04时01分，Cellectar Biosciences, Inc.股票出现异动，股价急速下跌5.59%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.54%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为1210.21%、246.97%、185.21%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Allarity Therapeutics, Inc.，振幅分别为272.73%、77.13%、47.90%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062604012196816b0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062604012196816b0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2444894210","title":"Cellectar Biosciences, Inc.盘中异动 急速上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444894210","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444894210?lang=zh_cn&edition=full","pubTime":"2024-06-20 22:06","pubTimestamp":1718892390,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日22时06分，Cellectar Biosciences, Inc.股票出现异动，股价急速拉升5.24%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Trevena, Inc.较为活跃，换手率分别为382.50%、187.56%、146.85%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Seastar Medical Holding Corp C/Wts 28/10/2027 、Trevena, Inc.，振幅分别为65244.36%、53.43%、37.87%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620220630af8e7546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620220630af8e7546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2444578435","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444578435","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444578435?lang=zh_cn&edition=full","pubTime":"2024-06-18 21:48","pubTimestamp":1718718535,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日21时48分，Cellectar Biosciences, Inc.股票出现异动，股价大幅跳水5.52%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Nls Pharmaceutics Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Mustang Bio, Inc.、Nls Pharmaceutics Ltd.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为342.12%、328.12%、293.54%，振幅较大的相关个股有Nls Pharmaceutics Ltd.、Mustang Bio, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为85.43%、52.69%、34.13%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618214856aef57910&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618214856aef57910&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2444586191","title":"Cellectar Biosciences, Inc.盘中异动 快速跳水5.43%报3.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444586191","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444586191?lang=zh_cn&edition=full","pubTime":"2024-06-17 23:28","pubTimestamp":1718638090,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日23时28分，Cellectar Biosciences, Inc.股票出现异动，股价大幅下跌5.43%。截至发稿，该股报3.05美元/股，成交量16.2814万股，换手率0.45%，振幅5.28%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Biorestorative Therapies, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为4521.43%、1580.69%、150.85%，振幅较大的相关个股有Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Biorestorative Therapies, Inc.，振幅分别为170.77%、53.30%、36.76%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061723281096814aaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061723281096814aaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2441006195","title":"Cellectar Biosciences, Inc.盘中异动 急速上涨5.61%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441006195","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441006195?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:51","pubTimestamp":1717768291,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时51分，Cellectar Biosciences, Inc.股票出现波动，股价快速上涨5.61%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nutriband Inc C/Wts 、杰龙涨幅较大，Biocardia, Inc.、Scinai Immunotherapeutics Ltd、Virax Biolabs Group Limited较为活跃，换手率分别为327.32%、97.87%、29.85%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Biocardia, Inc.，振幅分别为65.25%、62.99%、38.95%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607215131941ed4fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607215131941ed4fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2441209433","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.10%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441209433","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441209433?lang=zh_cn&edition=full","pubTime":"2024-06-06 01:08","pubTimestamp":1717607300,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日01时08分，Cellectar Biosciences, Inc.股票出现波动，股价急速上涨5.10%。截至发稿，该股报3.06美元/股，成交量19.4024万股，换手率0.54%，振幅5.67%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Kineta, Inc.、Rezolute, Inc.、诺瓦瓦克斯医药涨幅较大，Cns Pharmaceuticals, Inc.、Virios Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为126.69%、63.96%、51.50%，振幅较大的相关个股有Virios Therapeutics, Inc.、Kineta, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为66.83%、63.28%、54.10%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606010821aef39378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606010821aef39378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2439654769","title":"Cellectar Biosciences 和 City of Hope 癌症中心进入合作评估类真菌病中的 Iopofosine I 131","url":"https://stock-news.laohu8.com/highlight/detail?id=2439654769","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439654769?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:46","pubTimestamp":1716979565,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences 和 City of Hope 癌症中心进入合作评估类真菌病中的 Iopofosine I 131","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529184607957483ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529184607957483ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2439884355","title":"Cellectar Biosciences, Inc.盘中异动 股价大跌5.14%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439884355","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439884355?lang=zh_cn&edition=full","pubTime":"2024-05-29 01:04","pubTimestamp":1716915892,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日01时04分，Cellectar Biosciences, Inc.股票出现异动，股价大幅下挫5.14%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.95%。其相关个股中，Insmed Incorporated、Tc Biopharm  Plc C/Wts 10/02/2028 、Calliditas Therapeutics Ab涨幅较大，Mustang Bio, Inc.、Exicure, Inc.、Kintara Therapeutics, Inc.较为活跃，换手率分别为68.54%、59.37%、42.60%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Exicure, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为89.11%、77.00%、46.86%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290104529681048f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405290104529681048f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2438120096","title":"Cellectar Biosciences Inc申请高达3亿美元的混合货架——美国证券交易委员会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2438120096","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438120096?lang=zh_cn&edition=full","pubTime":"2024-05-25 04:54","pubTimestamp":1716584098,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences Inc申请高达3亿美元的混合货架——美国证券交易委员会备案","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525045459955ae335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525045459955ae335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2436198049","title":"Cellectar Biosciences, Inc.2024财年第一财季实现净利润-21.58百万美元，同比减少151.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436198049","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436198049?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:11","pubTimestamp":1716135103,"startTime":"0","endTime":"0","summary":"3月31日，Cellectar Biosciences, Inc.公布财报，公告显示公司2024财年第一财季净利润为-21.58百万美元，同比减少151.52%；其中营业收入为0.00美元，每股基本收益为-0.74美元。从资产负债表来看，Cellectar Biosciences, Inc.总负债16.74百万美元，其中短期债务73994.00美元，资产负债比为2.57，流动比率为2.55。机构评级：截至2024年3月31日，当前有4家机构对Cellectar Biosciences, Inc.目标价做出预测，其中目标均价为15.25美元，其中最低目标价为7.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200011568b1863e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200011568b1863e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB"],"gpt_icon":0},{"id":"2435951120","title":"Cellectar Biosciences, Inc.盘中异动 大幅上涨5.07%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435951120","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435951120?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:48","pubTimestamp":1715694484,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时48分，Cellectar Biosciences, Inc.股票出现异动，股价快速拉升5.07%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Generation Bio Co.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、诺瓦瓦克斯医药较为活跃，换手率分别为59.46%、10.71%、10.49%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Fennec Pharmaceuticals Inc.，振幅分别为65.81%、33.57%、27.54%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142148047a59d946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142148047a59d946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2434886969","title":"Cellectar Biosciences, Inc.盘中异动 急速下挫5.09%报3.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434886969","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434886969?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:04","pubTimestamp":1715357041,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日00时04分，Cellectar Biosciences, Inc.股票出现异动，股价大幅跳水5.09%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，诺瓦瓦克斯医药、Clene Inc C/Wts 30/12/2025 、Iteos Therapeutics, Inc.涨幅较大，Transcode Therapeutics, Inc.、诺瓦瓦克斯医药、Allarity Therapeutics, Inc.较为活跃，换手率分别为187.38%、92.10%、50.10%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028、Cardio Diagnostics Holdings Inc.，振幅分别为77.01%、70.00%、53.60%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110004017a594420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110004017a594420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2432757908","title":"Cellectar Biosciences, Inc.盘中异动 快速上涨5.09%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432757908","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432757908?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:47","pubTimestamp":1714744028,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时47分，Cellectar Biosciences, Inc.股票出现波动，股价快速上涨5.09%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Vaxxinity, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为103.30%、26.77%、15.93%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Effector Therapeutics Inc C/Wts 31/12/2025 、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为54.50%、30.65%、26.55%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503214708861ead81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503214708861ead81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","VAXX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectar.com","stockEarnings":[{"period":"1week","weight":0.1577},{"period":"1month","weight":-0.1335},{"period":"3month","weight":-0.1308},{"period":"6month","weight":-0.2119},{"period":"1year","weight":0.6221},{"period":"ytd","weight":0.0072}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectar Biosciences, Inc.以前名为Novelos Therapeutics, Inc.于1996年6月成立于特拉华州。2014年2月11日，公司更名为现在的名字。它是一家生物制药公司，开发用于治疗肿瘤成像化合物。该公司的癌症靶向技术允许选择性递送的多种剂对癌症细胞，包括癌症干细胞。该公司目前正在开发三种专利的候选产品：I-124-CLR1404 是一种小分子，广谱，肿瘤的靶向性的正电子发射断层扫描（PET）显像剂，该公司认为其必须在范围广泛的癌症肿瘤和转移的选择性检测的第一种可能。I-131-CLR1404是一种小分子，广谱，癌靶向分子放射治疗的直接和选择性地提供细胞毒性（细胞杀伤）辐射到癌细胞和癌干细胞。CLR1502是一种临床前，小分子，肿瘤靶向，非放射性的光学成像术中肿瘤边缘照明和非侵入性的肿瘤成像剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.027916},{"month":2,"riseRate":0.6,"avgChangeRate":0.012926},{"month":3,"riseRate":0.5,"avgChangeRate":-0.02847},{"month":4,"riseRate":0.2,"avgChangeRate":-0.095326},{"month":5,"riseRate":0.3,"avgChangeRate":0.04729},{"month":6,"riseRate":0.4,"avgChangeRate":-0.071836},{"month":7,"riseRate":0.4,"avgChangeRate":-0.048401},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.019682},{"month":9,"riseRate":0.4,"avgChangeRate":-0.041969},{"month":10,"riseRate":0.1,"avgChangeRate":-0.147573},{"month":11,"riseRate":0.4,"avgChangeRate":-0.05683},{"month":12,"riseRate":0.4,"avgChangeRate":0.02288}],"exchange":"NASDAQ","name":"Cellectar Biosciences Inc.","nameEN":"Cellectar Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectar Biosciences Inc.,CLRB,Cellectar Biosciences Inc.股票,Cellectar Biosciences Inc.股票老虎,Cellectar Biosciences Inc.股票老虎国际,Cellectar Biosciences Inc.行情,Cellectar Biosciences Inc.股票行情,Cellectar Biosciences Inc.股价,Cellectar Biosciences Inc.股市,Cellectar Biosciences Inc.股票价格,Cellectar Biosciences Inc.股票交易,Cellectar Biosciences Inc.股票购买,Cellectar Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况